Juliette Foucher

Om mig

After seven years spent in Canada, completing my Master's Degree in
Neuroscience and working in clinical research, I joined the team of Dr
Caroline Ingre in December 2020 to work with her on ALS clinical trials.

Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2024;25(7-8):795-796
THE INTERNATIONAL NETWORK FOR ALS RESEARCH AND CARE (INARC)
Foucher J; Bunte T; Verschoor R; Straub C; Couillard M; Bertone V
Article: JOURNAL OF NEUROLOGY. 2024;271(8):5267-5274
Repeated cognitive assessments show stable function over time in patients with ALS
Oijerstedt L; Foucher J; Lovik A; Yazdani S; Juto A; Klappe U; Fang F; Ingre C
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2024;25(7-8):708-716
ECAS correlation with metabolic alterations on FDG-PET imaging in ALS
Foucher J; Oijerstedt L; Lovik A; Sun J; Ismail M-A; Sennfalt S; Savitcheva I; Estenberg U; Pagani M; Fang F; Pereira JB; Ingre C
Article: EUROPEAN JOURNAL OF NEUROLOGY. 2023;30(12):3722-3731
A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis
Weemering DN; Midei M; Milner P; Gopalakrishnan V; Kumar A; Dannenberg AJ; Bunte TM; Foucher J; Ingre C; Kenina V; Rallmann K; van den Berg LH; van Eijk RPA
Article: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2023;24(7-8):1-6
Validity and reliability measures of the Swedish Karolinska version of the Edinburgh Cognitive and Behavioral ALS Screen (SK-ECAS)
Foucher J; Winroth I; Lovik A; Sennfalt S; Pereira JBB; Fang F; Lule D; Andersen PMM; Ingre C

Review: SYSTEMATIC REVIEWS. 2024;13(1):111
The usage of population and disease registries as pre-screening tools for clinical trials, a systematic review
Foucher J; Azizi L; Oeijerstedt L; Klaeppe U; Ingre C
Meeting abstract: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2021;22(sup2):150-173
Using a patient-based registry as a pre-screening tool for ALS trials: the role of vital capacity
Wellander T; Foucher J; Ingre C; Fang F; Jacobsson E-C
Meeting abstract: AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION. 2021;22(sup2):135-149
Cognitive dysfunction evaluated by the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) correlates with the 18F-FDG-PET metabolic patterns in amyotrophic lateral sclerosis (ALS)
Foucher J; Lovik A; Hellqvist J; Pagani M; Pereira J; Savitcheva I; Estenberg U; Ingre C
Conference publication: ENDOSCOPY. 2019;51(04):s91
THE POLYP-BASED RESECT-AND-DISCARD STRATEGY: A PROSPECTIVE STUDY
Hammar C; Frenn M; Pohl H; Foucher J; Bouin M; Deslandres E; Bouchard S; Renteln D
Meeting abstract:
Could both SNIP and TCCO2 replace FVC as an eligibility criteria for ALS clinical trials? A retrospective chart review.
Foucher J; Genge A
Meeting abstract:
Validity and reliability measures of the Swedish version of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS)
Foucher J; Lovik A; Sennfält S; Fang F; Ingre C